BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding P, Li L, Li L, Lv X, Zhou D, Wang Q, Chen J, Yang C, Xu E, Dai W, Zhang X, Wang N, Wang Q, Zhang W, Zhang L, Zhou Y, Gu H, Lei Q, Zhou X, Hu W. C5aR1 is a master regulator in Colorectal Tumorigenesis via Immune modulation. Theranostics 2020;10:8619-32. [PMID: 32754267 DOI: 10.7150/thno.45058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Ye S, Yang B, Zhang T, Wei W, Li Z, Chen J, Li X. Identification of an Immune-Related Prognostic Signature for Glioblastoma by Comprehensive Bioinformatics and Experimental Analyses. Cells 2022;11:3000. [DOI: 10.3390/cells11193000] [Reference Citation Analysis]
2 Spera MC, Cesta MC, Zippoli M, Varrassi G, Allegretti M. Emerging Approaches for the Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN): Therapeutic Potential of the C5a/C5aR Axis. Pain Ther 2022. [PMID: 36098939 DOI: 10.1007/s40122-022-00431-8] [Reference Citation Analysis]
3 Senent Y, Tavira B, Pio R, Ajona D. The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells. Cancer Lett 2022;549:215900. [PMID: 36087681 DOI: 10.1016/j.canlet.2022.215900] [Reference Citation Analysis]
4 Zahid KR, Raza U, Tumbath S, Jiang L, Xu W, Huang X. Neutrophils: Musketeers against immunotherapy. Front Oncol 2022;12:975981. [DOI: 10.3389/fonc.2022.975981] [Reference Citation Analysis]
5 Liu Z, Yu Y, Kang W, Chen F, Yan F, Ma B, Ge S. Self-assembled terbium-amino acid nanoparticles as a model for terbium biosafety and bone repair ability assessment. Composites Part B: Engineering 2022. [DOI: 10.1016/j.compositesb.2022.110186] [Reference Citation Analysis]
6 Bi Q, Wu JY, Qiu XM, Zhang JD, Sun ZJ, Wang W. Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis. J Immunol Res 2022;2022:3128933. [PMID: 35733919 DOI: 10.1155/2022/3128933] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Brandolini L, d'Angelo M, Novelli R, Castelli V, Giorgio C, Sirico A, Cocchiaro P, D'Egidio F, Benedetti E, Cristiano C, Bugatti A, Ruocco A, Amendola PG, Talarico C, Manelfi C, Iaconis D, Beccari A, Quadros AU, Cunha TM, Caruso A, Russo R, Cimini A, Aramini A, Allegretti M. Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions. Cell Death Dis 2022;13:500. [PMID: 35614037 DOI: 10.1038/s41419-022-04964-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Johnson EM, Uppalapati CK, Pascual AS, Estrada SI, Averitte RL, Leyva KJ, Hull EE. Complement Factor H in cSCC: Evidence of a Link Between Sun Exposure and Immunosuppression in Skin Cancer Progression. Front Oncol 2022;12:819580. [PMID: 35223500 DOI: 10.3389/fonc.2022.819580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
9 Talaat IM, Elemam NM, Saber-ayad M. Complement System: An Immunotherapy Target in Colorectal Cancer. Front Immunol 2022;13:810993. [DOI: 10.3389/fimmu.2022.810993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhu Y, Wang X, Xu Y, Chen L, Ding P, Chen J, Hu W. An Integrated Analysis of C5AR2 Related to Malignant Properties and Immune Infiltration of Breast Cancer. Front Oncol 2021;11:736725. [PMID: 34595119 DOI: 10.3389/fonc.2021.736725] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Yu L, Yao T, Jiang Z, Xu T. Integrated Analysis of miRNA-mRNA Regulatory Networks Associated with Osteonecrosis of the Femoral Head. Evid Based Complement Alternat Med 2021;2021:8076598. [PMID: 34422080 DOI: 10.1155/2021/8076598] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Zhao X, Li H, Lyu S, Zhai J, Ji Z, Zhang Z, Zhang X, Liu Z, Wang H, Xu J, Fan H, Kou J, Li L, Lang R, He Q. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma. Int J Biol Sci 2021;17:2590-605. [PMID: 34326696 DOI: 10.7150/ijbs.58886] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
13 O'Brien RM, Cannon A, Reynolds JV, Lysaght J, Lynam-Lennon N. Complement in Tumourigenesis and the Response to Cancer Therapy. Cancers (Basel) 2021;13:1209. [PMID: 33802004 DOI: 10.3390/cancers13061209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
14 Revel M, Daugan MV, Sautés-Fridman C, Fridman WH, Roumenina LT. Complement System: Promoter or Suppressor of Cancer Progression? Antibodies (Basel) 2020;9:E57. [PMID: 33113844 DOI: 10.3390/antib9040057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]